RESERVED AREA Menu What is pharmacovigilance Pharmacovigilance is the set of activities aimed at identifying, evaluating, understanding and preventing adverse effects (also called "adverse reactions") potentially related to the use of medicines, to ensure a favorable risk / benefit ratio for the population. The aim of Pharmacovigilance is to better define the safety of use of medicines, improve the way they are used and establish a safety profile that corresponds to real medical practice. HOW TO MAKE A REPORT OF SUSPECTED ADVERSE REACTION To report a suspected adverse reaction that occurs following the use of a DOC Generici drug, you can do one of the following: Compilare l’apposita scheda di segnalazione reperibile al seguente link https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse ed inviarla al Responsabile di Farmacovigilanza della propria ASL di appartenenza via e-mail o fax ai recapiti disponibili al seguente indirizzo: https://www.aifa.gov.it/responsabili-farmacovigilanza Seguire la procedura guidata direttamente online sul sito www.vigifarmaco.it In alternativa, è possibile effettuare la segnalazione direttamente all’Azienda ai recapiti indicati di seguito: E-mail: farmacovigilanza@genericidoc.it Tel: +39 02 65534273 Fax: +39 02 65534275 DOC GENERICI S.R.L. Società a responsabilità limitata con unico socio Via Filippo Turati, 40 – Milano (ITALY) Phone: (+39) 02 655341 Email: segreteria@genericidoc.it Email of the Data Protection Officer: DPO@genericidoc.it To report any adverse effects that occur following the use of a DOC Generici drug, consult the Pharmacovigilance section TERMS AND CONDITIONS SUPPLIER INFORMATION PHARMACOVIGILANCE INFORMATION PRIVACY POLICY COOKIE POLICY © 2020 All Rights Reserved by DOC Generici PI / RI 11845960159 • REA 1502371 • Share Capital € 1,560,000 fully paid-up Disclosure We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, also for other purposes ("simple interactions and functionality", "experience improvement", "measurement" and "targeting and advertising") such as specified in the cookie policy . You can consent to the use of these technologies by closing this statement. Learn more and customize Accept ×